Indications
Progesterone deficiency conditions in women:
For oral use:
– threatening abortion or the prevention of habitual abortion due to lack of progesterone;
– infertility due to luteal insufficiency;
– premenstrual syndrome;
– disorders of the menstrual cycle due to violation of ovulation or anovulation;
– fibrocystic mastopathy;
– period of the menopausal transition;
– menopausal (substitution) hormone therapy (MHT) in peri – and postmenopausal women (in combination with èstrogensoderžaŝimi drugs).
For intravaginal use:
– MGT in the case of progesterone deficiency with non-functioning (missing) ovaries (egg donation);
– the prevention (prophylaxis) of preterm birth in women at-risk (with a short cervix and/or the presence of anamnestic data of preterm birth and/or premature rupture of membranes);
– support the luteal phase in preparation for in vitro fertilization;
– support the luteal phase in spontaneous or induced menstrual cycle;
premature menopause;
– MGT (in combination with èstrogensoderžaŝimi drugs);
– infertility due to luteal insufficiency
– threatening abortion or the prevention of habitual abortion due to lack of progesterone.
Reviews
There are no reviews yet